Donor-specific Antibodies, Immunoglobulin-free Light Chains, and BAFF Levels in Relation to Risk of Late-onset PTLD in Liver Recipients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Donor-specific Antibodies, Immunoglobulin-free Light Chains, and BAFF Levels in Relation to Risk of Late-onset PTLD in Liver Recipients

Published:2018-06 Issue:6 Volume:4 Page:e353
ISSN:2373-8731
Container-title:Transplantation Direct
language:en
Short-container-title:Transplantation Direct

Author:

Engels Eric A.,Jennings Linda W.,Everly Matthew J.,Landgren Ola,Murata Kazunori,Yanik Elizabeth L.,Pfeiffer Ruth M.,Onaca Nicholas,Klintmalm Goran B.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference21 articles.

1. Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States;Am J Hematol,2011

2. Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States;Am J Hematol,2014

3. Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases?;Transplantation,2005

4. HLA and risk of diffuse large B-cell lymphoma after solid organ transplantation;Transplantation,2016

5. The role of donor-specific HLA alloantibodies in liver transplantation;Am J Transplant,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening and Management of PTLD;Transplantation;2023-10-21

2. The IPTA Nashville Consensus Conference on Post‐Transplant lymphoproliferative disorders after solid organ transplantation in children: III – Consensus guidelines for Epstein‐Barr virus load and other biomarker monitoring;Pediatric Transplantation;2023-06-09

3. Non-invasive monitoring associated with B lymphoma cells in post-transplant lymphoproliferative disorder (PTLD) patients: Systematic review;Human Antibodies;2023-05-15

4. Long-Term Outcome of Kidney Failure in Children;Pediatric Kidney Disease;2023

5. Clinical Post-Transplant Lymphoproliferative Disorders;Cardiovascular & Hematological Disorders-Drug Targets;2022-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3